Australian Trachoma Surveillance Report 2013

List of figures

Page last updated: 2015

Figure 1.1 Trachoma prevalence in children aged 5-9 years in at-risk communities in Australia, 2013

Figure 1.2 Number of communities at-risk by year and jurisdiction, Australia, 2007 – 2013

Figure 1.3 Number of at-risk communities by jurisdiction, according to trachoma control strategy implemented, Australia, 2013

Figure 1.4 Population screening coverage in communities that were screened for trachoma by jurisdiction, Australia, 2013

Figure 1.5 Proportion of screened children aged 5-9 years who had a clean face by year and jurisdiction, Australia, 2007-2013

Figure 1.6 Trachoma prevalence among screened children aged 5-9 years by year and jurisdiction, Australia, 2007-2013

Figure 1.7 Number of screened at-risk communities according to level of trachoma prevalence in 5-9-year-old children in 2013, by jurisdiction, Australia

Figure 1.8 Number of communities according to number of years of trachoma prevalence under 5%, by jurisdiction in Australia, 2013

Figure 1.9 Number of doses of azithromycin administered for the treatment of trachoma by Jurisdiction in Australia, 2007-2013

Figure 2.1 Trachoma prevalence in children aged 5-9 years, number of communities that were screened treated or both for trachoma and number of at-risk communities in the Northern Territory, 2013

Figure 2.2 Number of communities at-risk by region in the Northern Territory, 2007-2013

Figure 2.3 Number of at-risk communities by region, according to trachoma control strategy implemented, Northern Territory 2013

Figure 2.4 Population screening coverage in communities that required screening for trachoma by region in the Northern Territory, 2013

Figure 2.5 Proportion of screened children aged 5-9 years who had a clean face by region in the Northern Territory, 2007-2013

Figure 2.6a Trachoma prevalence among children aged 5-9 years in communities that were screened by region in the Northern Territory, 2007-2013

Figure 2.6b Trachoma prevalence among children aged 5-9 years by region in the Northern Territory with projected values, 2007-2013

Figure 2.7 Number of at-risk communities according to level of trachoma prevalence in 5-9-year-old children in 2013, by region in the Northern Territory

Figure 2.8 Communities according to number of years of trachoma prevalence under 5% by Northern Territory Region, 2013

Figure 2.9 Number of doses of azithromycin administered for the treatment of trachoma by Northern Territory region, 2007-2013

Figure 3.1 Trachoma prevalence in children aged 5-9 years, number of communities that were screened treated or both for trachoma and number of at-risk communities in South Australia, 2013

Figure 3.2 Number of communities at-risk by region in South Australia, 2007-2013

Figure 3.3 Number of at-risk communities by region, according to trachoma control strategy implemented, South Australia, 2013

Figure 3.4 Population screening coverage in at-risk communities that required screening for trachoma by region in South Australia in 2013

Figure 3.5 Proportion of screened children* aged 5-9 years who had a clean face by region in South Australia, 2007-2013

Figure 3.6 Trachoma prevalence among children aged 5-9 year in at-risk communities that were screened by region in South Australia, 2007-2013

Figure 3.7 Number of at-risk communities according to level of trachoma prevalence in 5-9-year-old children in 2013, by South Australia

Figure 3.8 At-risk communities according to number of years* of trachoma prevalence under 5% by South Australian region

Figure 3.9 Number of doses of azithromycin administered for the treatment of trachoma by South Australian region, 2007-2013

Figure 4.1 Trachoma prevalence in children aged 5-9 years, number of communities that were screened treated or both for trachoma and number of at-risk communities in Western Australia, 2013

Figure 4.2 Number of communities at-risk by region in Western Australia, 2007-2013

Figure 4.3 Number of at-risk communities by region, according to trachoma control strategy implemented, Western Australia, 2013

Figure 4.4 Population screening coverage in communities that required screening for trachoma by region in Western Australia in 2013

Figure 4.5 Proportion of screened children aged 5-9 years who had a clean face by region in Western Australia, 2007-2013

Figure 4.6 Trachoma prevalence among children aged 5-9 year in communities that were screened by region in Western Australia, 2007-2013

Figure 4.7 Number of at-risk communities according to level of trachoma prevalence in 5-9-year-old children in 2013, by region in Western Australia

Figure 4.8 Communities according to number of years* of trachoma prevalence under 5% by Western Australia region

Figure 4.9 Number of doses of azithromycin administered for the treatment of trachoma by Western Australia region, 2007-2013

Figure 5.1 Trachoma prevalence in children aged 5-9 years, number of communities that were screened treated or both for trachoma and number of potentially at-risk communities in NSW, 2013

Top of page